Home›Stock Screener›SMS Pharmaceuticals›Quarterly Results

SMS Pharmaceuticals Quarterly Results

Latest Quarter Net Profit
₹33 Cr
QMar 2026
Quarterly Results

SMS Pharmaceuticals quarterly results. In Mar 2026, SMS Pharmaceuticals (SMSPHARMA) reported revenue ₹241 Cr and net profit ₹33 Cr — revenue -3.6% YoY. Review SMS Pharmaceuticals price earnings to evaluate earnings-based valuation against sector peers.

SMSPHARMA Quarterly Results — Revenue, Profit & EPS Highlights

SMS Pharmaceuticals latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit SMSPHARMA stock price BSE.

  • Revenue of ₹241 Cr in Mar 2026 (+15.3% vs Jun 2026, -3.6% vs Mar 2025)
  • Net Profit of ₹33 Cr in Mar 2026 (+57.1% vs Jun 2026, +65.0% vs Mar 2025)
  • EBITDA of ₹43 Cr in Mar 2026 (+0.0% vs Jun 2026)
  • Operating Margin of 17.0% in Mar 2026 (-3.0pp vs Jun 2026)
  • Earnings Per Share of ₹3.58 in Mar 2026 (+60.5% vs Jun 2026)

SMS Pharmaceuticals Quarterly Results — Revenue, EBITDA, Net Profit & EPS

SMSPHARMA quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 241 209 244 250 197 15.3% -3.6%
Net Profit (₹ Cr) 33 21 25 20 21 - -
EBITDA (₹ Cr) 43 43 50 42 40 - -
EPS (₹) 3.58 2.23 2.84 2.40 2.31 - -
Operating Margin (%) 17.0% 20.0% 20.0% 16.0% 20.0% - -

SMSPHARMA Share Price Trend — 1-Year Movement Across Quarterly Results

SMS Pharmaceuticals 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Check SMSPHARMA market capitalization to track the company's total market size over time.

Profitability Ratios

Profit Margin 13.7%
EBITDA Margin 17.8%
Operating Margin 17.0%
ROE (Annual) 16.8%

Balance Sheet Highlights

Total Assets ₹1,362 Cr
Total Equity ₹786 Cr
Current Assets ₹638 Cr
Current Liabilities ₹224 Cr

Cash Flow Analysis

Operating Cash Flow ₹82 Cr
Investing Cash Flow ₹-123 Cr
Financing Cash Flow ₹47 Cr
Net Cash Flow ₹5 Cr

Current Market Data

Current Price ₹477.85
Exchange NSE
Last Updated Oct 05, 2026

Revenue Trend (₹ Cr)

Mar 2025 250
Sept 2025 244
Jun 2026 209
Mar 2026 241

Net Profit Trend (₹ Cr)

Mar 2025 20
Sept 2025 25
Jun 2026 21
Mar 2026 33

Operating Margin Trend (%)

Mar 2025 16.0%
Sept 2025 20.0%
Jun 2026 20.0%
Mar 2026 17.0%

SMSPHARMA vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

SMS Pharmaceuticals latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹432,120.23 Cr 1779.7 15,018 2,710 -5.6% - 18.0% 157.5
Divis Laboratories
Mar 2026 		₹253,522.49 Cr 9196.0 2,986 751 -5.0% - 25.2% 324.8
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4772.0 4,111 364 +27.7% +42.2% 8.9% 414.6
Zydus Life Science
Mar 2026 		₹113,615.69 Cr 1139.0 7,569 1,341 -4.3% - 17.7% 90.0
Cipla
Mar 2026 		₹108,576.18 Cr 1335.5 6,612 543 -9.3% - 8.2% 194.4
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores